Metraipolis › archive › dc_7ca012dd0ae6
Non-clinical safety considerations on genome editing using the CRISPR/Cas system — Europe PMC PMID:41362674
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41362674
- DOI
- 10.1016/j.gendis.2025.101785
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T02:35:05.391Z
- SHA-256 of the archived text
aa6a46a7083590947cfd8616a05de974f96a7ac76d815e4548a71a6127046e40- Stable URL of this page
https://metraipolis.com/documento/dc_7ca012dd0ae6
How to cite
Non-clinical safety considerations on genome editing using the CRISPR/Cas system — Europe PMC PMID:41362674 — Europe PMC (en), https://europepmc.org/article/MED/41362674 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ca012dd0ae6 (Metraipolis archive dc_7ca012dd0ae6, sha256 aa6a46a7083590947cfd8616a05de974f96a7ac76d815e4548a71a6127046e40)
BibTeX
@misc{dc7ca012dd0ae6,
title = {Non-clinical safety considerations on genome editing using the CRISPR/Cas system — Europe PMC PMID:41362674},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41362674},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ca012dd0ae6; sha256 aa6a46a7083590947cfd8616a05de974f96a7ac76d815e4548a71a6127046e40},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41362674. Agents can read the archived copy with the MCP tool read_document.